Improve process uniformity and cell viability in cryopreservation

BioProcess International

Volumn 10, Issue 4, 2012, Pages 70-76

  Zhou, Ying ^a   Fowler, Zachary ^b   Cheng, Alan ^b   Sever, Robert ^b  

^a PRAXAIR INC   (United States)

^b NONE

Author keywords

Cell viability; Design of experiments; Freezing thawing; Media; Temperature control

Indexed keywords

CELL VIABILITY; CRYOPRESERVATION; FREEZE THAWING; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; SHORT SURVEY; STORAGE TEMPERATURE;

EID: 84861676529     PISSN: 15426319     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Short Survey

References (7)

1. Jain KK. Cell Therapy. Jain PharmaBiotech: Basel, Switzerland, August 2010.
2. Mathew AJ. I'm Losing Cell Viability and Function at Different Points in My Process, and I Don't Know Why! BioProcess Int. 8(6) 2010: 54-47.
3. Rowley JA. Developing Cell Therapy Biomanufacturing Processes. SPE November 2011: S50-S55.
4. Brandenberger R, et al. Cell Therapy BioProcessing. BioProcess Int. 3(9) 2011: 30-37.
5. Buckler RL. Opportunities in Regenerative Medicine. BioProcess Int. 3(9) 2011: 14-19.
6. Cheng A. Method and System for Controlled Rate Freezing of Biological Material. International Patent WO 2009/062025 A2, 14 May 2009.
7. Karlsson J, et al. Fertilization and Development of Mouse Oocytes and Cryopreserved Using a Theoretically Optimized Protocol. Hum. Reprod. 11(3) 1996: 1296-1305. (Pubitemid 26245334)